Platform trials streamline ALS therapy evaluation by rapidly ruling out ineffective drugs
Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...
Contract Pharma1d
Biologics R&D: Derisking Scale-up and Tox Supply
As a biologics CDMO focused on developing and manufacturing recombinant protein products using mammalian cell culture ...
Positive Long-Term Outlook for Narrow-Moat Siegfried as Drug Outsourcing Demand Remains Strong
We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...